Corvus Pharmaceuticals, Inc. Share Price
NASDAQ: CRVSHealthcare
Live Corvus Pharmaceuticals, Inc. Share Price Chart
O H L
Corvus Pharmaceuticals, Inc. Performance Overview
Days Range
▼
$12.31Low
$12.54High
Markets Today
| Previous Close | $12.55 |
|---|---|
| Open | $12.54 |
| Volume | 145,291 |
| Day's Range | $12.31 - $12.54 |
| 52W Range | $5.72 - $26.95 |
| Market Cap | $1.03 B |
Historical Performance
| 1M Returns | -15.37 |
|---|---|
| 3M Returns | +5.37 |
| 6M Returns | -10.87 |
| 1Y Returns | +105.07 |
| 5Y Returns | +135.90 |
| 10Y Returns | -14.92 |
Corvus Pharmaceuticals, Inc. Fundamentals
| Market Cap | $1.03 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -0.33 |
| EPS TTM | $-0.62 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 4.57 |
| EBITDA | $-42.87 M |
| Profit Margin | N/A |
| Market Cap | $1.03 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -0.33 |
| EPS TTM | $-0.62 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 4.57 |
| EBITDA | $-42.87 M |
| Profit Margin | N/A |
Corvus Pharmaceuticals, Inc. Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit + | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$9.92 M | -$10.26 M | -$10.57 M | -$12.22 M | -$14.88 M | -$19.30 M |
| EBITDA | -$9.90 M | -$10.23 M | -$10.54 M | -$12.19 M | -$14.85 M | -$19.26 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $22.00 K | $29.00 K | $28.00 K | $26.00 K | $29.00 K | $34.00 K |
| Income Before Tax | $15.73 M | -$8.00 M | -$9.83 M | -$13.57 M | -$13.09 M | -$17.96 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | $15.19 M | -$8.00 M | -$10.16 M | -$12.32 M | -$13.69 M | -$17.96 M |
| Net Profit Margin | - | - | - | - | - | - |
Corvus Pharmaceuticals, Inc. Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $7.00 K | $7.00 K | $7.00 K | $7.00 K | $8.00 K | $8.00 K |
| Reserve & Surplus | -$383.07 M | -$390.96 M | -$401.03 M | -$413.19 M | -$427.11 M | -$445.24 M |
| Non-Current Liabilities | $834.00 K | $728.00 K | $632.00 K | $534.00 K | $406.00 K | $274.00 K |
| Current Liabilities | $9.28 M | $8.51 M | $8.07 M | $9.38 M | $12.11 M | $13.67 M |
| Total Liabilities | $10.11 M | $9.23 M | $8.71 M | $9.91 M | $12.52 M | $13.95 M |
| Fixed Assets | $165.00 K | $249.00 K | $221.00 K | $220.00 K | $282.00 K | $830.00 K |
| Current Assets | $45.49 M | $75.78 M | $66.94 M | $58.21 M | $239.95 M | $220.97 M |
| Total Assets | $59.44 M | $89.46 M | $80.47 M | $71.12 M | $253.19 M | $239.27 M |
Corvus Pharmaceuticals, Inc. Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | $15.19 M | -$8.00 M | -$10.16 M | -$12.32 M | -$13.69 M | -$17.96 M |
| Operating Cash Flow | -$8.26 M | -$5.78 M | -$9.57 M | -$9.19 M | -$10.37 M | -$15.40 M |
| Investing Cash Flow | $4.24 M | -$20.30 M | -$2.62 M | $10.88 M | -$144.85 M | -$5.96 M |
| Financing Cash Flow | $279.00 K | $35.77 M | $360.00 K | $20.00 K | $190.75 M | $166.00 K |
| Change in Cash | -$3.74 M | $9.69 M | -$11.82 M | $1.71 M | $35.53 M | -$21.20 M |
Corvus Pharmaceuticals, Inc. Return Calculator
The Corvus Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$23,252
Invested Amount$10,000
Est. Returns$13,252
About Corvus Pharmaceuticals, Inc.
Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.
Popular Stocks
FAQs
What is the share price of Corvus Pharmaceuticals, Inc. today?
Corvus Pharmaceuticals, Inc. (CRVS) share price as of September 18, 2026 is $12.37. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Corvus Pharmaceuticals, Inc.?
Yes, Indian Investors can invest in the Corvus Pharmaceuticals, Inc. (CRVS) Share by opening an international trading account with Angel One.
How can I purchase Corvus Pharmaceuticals, Inc. shares in India?
Purchasing Corvus Pharmaceuticals, Inc. (CRVS) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Corvus Pharmaceuticals, Inc. (CRVS) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Corvus Pharmaceuticals, Inc.?
Yes, you can purchase fractional shares of Corvus Pharmaceuticals, Inc. (CRVS) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Corvus Pharmaceuticals, Inc.?
The market capitalization of Corvus Pharmaceuticals, Inc. on September 18, 2026, is $1.03 B.
In which sector Corvus Pharmaceuticals, Inc. belongs?
Corvus Pharmaceuticals, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Corvus Pharmaceuticals, Inc. stocks?
In order to invest in Corvus Pharmaceuticals, Inc. (CRVS) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
